BCAB : Insider Transactions for Bioatla, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bioatla, Inc. (BCAB)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

46,110,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile BioAtla is a biopharmaceutical company engaged in developing specific and selective antibody-based therapeutics for the treatment of various cancers. Co.'s lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. Co. also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	81,495	83,495	252,735
Total Buy Value	$0	$172,540	$177,620	$814,041
Total People Bought	0	4	4	4
Total Buy Transactions	0	4	5	15
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-01	2023-10-31	2023-05-02	2022-05-02

Adjust Filter Settings

Records found: 207

Page 7 of 9

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Short Jay M Phd

Chief Executive Officer

• • •

2021-11-30

4

S

$24.00

$453,154

D/D

(18,490)

1,349,943

-

Waldron Richard A

Chief Financial Officer

• – –

2021-11-30

4

S

$24.00

$135,040

D/D

(5,510)

143,149

-

Vasquez Christian

See Remarks

• – –

2021-11-29

4

S

$23.89

$15,337

D/D

(642)

27,238

-

Short Jay M Phd

Chief Executive Officer

• • •

2021-11-29

4

S

$23.89

$368,742

D/D

(15,435)

1,368,433

-

Smith Scott Andrew

President

• • –

2021-11-29

4

S

$23.89

$9,532

D/D

(399)

349,746

-

Chief Medical Officer

• – –

2021-11-29

4

S

$23.89

$2,628

D/D

(110)

92,630

-

Waldron Richard A

Chief Financial Officer

• – –

2021-11-29

4

S

$23.89

$109,870

D/D

(4,599)

148,659

-

Smith Scott Andrew

President

• • –

2021-11-24

4

S

$24.05

$11,589

D/D

(466)

350,145

-

Chief Medical Officer

• – –

2021-11-24

4

S

$24.05

$3,208

D/D

(129)

92,740

-

Short Jay M Phd

Chief Executive Officer

• • •

2021-11-24

4

S

$24.05

$423,314

D/D

(17,022)

1,383,868

-

Vasquez Christian

See Remarks

• – –

2021-11-24

4

S

$24.05

$18,651

D/D

(750)

27,880

-

Waldron Richard A

Chief Financial Officer

• – –

2021-11-24

4

S

$24.05

$97,909

D/D

(3,937)

153,258

-

Smith Scott Andrew

President

• • –

2021-11-23

4

S

$24.29

$17,047

D/D

(684)

350,611

-

Chief Medical Officer

• – –

2021-11-23

4

S

$24.29

$4,660

D/D

(187)

92,869

-

Short Jay M Phd

Chief Executive Officer

• • •

2021-11-23

4

S

$24.29

$621,634

D/D

(24,943)

1,400,890

-

Vasquez Christian

See Remarks

• – –

2021-11-23

4

S

$24.29

$27,415

D/D

(1,100)

28,630

-

Waldron Richard A

Chief Financial Officer

• – –

2021-11-23

4

S

$24.29

$143,801

D/D

(5,770)

157,195

-

Smith Scott Andrew

President

• • –

2021-11-22

4

S

$26.24

$11,281

D/D

(430)

351,295

-

Chief Medical Officer

• – –

2021-11-22

4

S

$26.24

$3,096

D/D

(118)

93,056

-

Short Jay M Phd

Chief Executive Officer

• • •

2021-11-22

4

S

$26.24

$411,234

D/D

(15,675)

1,425,833

-

Vasquez Christian

See Remarks

• – –

2021-11-22

4

S

$26.24

$18,128

D/D

(691)

29,730

-

Waldron Richard A

Chief Financial Officer

• – –

2021-11-22

4

S

$26.24

$95,128

D/D

(3,626)

162,965

-

Steinman Lawrence

Director

– • –

2021-11-02

4

AS

$30.00

$13,500

D/D

(450)

18,459

-

Smith Scott Andrew

President

• • –

2021-10-01

4

S

$30.18

$90,351

D/D

(2,994)

351,725

-

Chief Medical Officer

• – –

2021-10-01

4

S

$30.39

$17,993

D/D

(592)

93,174

-

207 Records found	1 2 3 4 5 6 7 8 9	Page 7 of 9

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.